Glascock J - Search Results

1

Identifying Biomarkers of Spinal Muscular Atrophy for Further Development.

Glascock J, Darras BT, Crawford TO, Sumner CJ, Kolb SJ, DiDonato C, Elsheikh B, Howell K, Farwell W, Valente M, Petrillo M, Tingey J, Jarecki J. Glascock J, et al. J Neuromuscul Dis. 2023;10(5):937-954. doi: 10.3233/JND-230054. J Neuromuscul Dis. 2023. PMID: 37458045 Free PMC article.

2

Delivery of therapeutic agents through intracerebroventricular (ICV) and intravenous (IV) injection in mice.

Glascock JJ, Osman EY, Coady TH, Rose FF, Shababi M, Lorson CL. Glascock JJ, et al. J Vis Exp. 2011 Oct 3;(56):2968. doi: 10.3791/2968. J Vis Exp. 2011. PMID: 21988897 Free PMC article.

3

Astrocytes influence the severity of spinal muscular atrophy.

Rindt H, Feng Z, Mazzasette C, Glascock JJ, Valdivia D, Pyles N, Crawford TO, Swoboda KJ, Patitucci TN, Ebert AD, Sumner CJ, Ko CP, Lorson CL. Rindt H, et al. Among authors: glascock jj. Hum Mol Genet. 2015 Jul 15;24(14):4094-102. doi: 10.1093/hmg/ddv148. Epub 2015 Apr 24. Hum Mol Genet. 2015. PMID: 25911676 Free PMC article.

4

Cure SMA and our patient community celebrate the first approved drug for SMA.

Glascock J, Lenz M, Hobby K, Jarecki J. Glascock J, et al. Gene Ther. 2017 Sep;24(9):498-500. doi: 10.1038/gt.2017.39. Epub 2017 May 15. Gene Ther. 2017. PMID: 28504658 Review.

5

Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening.

Glascock J, Sampson J, Haidet-Phillips A, Connolly A, Darras B, Day J, Finkel R, Howell RR, Klinger K, Kuntz N, Prior T, Shieh PB, Crawford TO, Kerr D, Jarecki J. Glascock J, et al. J Neuromuscul Dis. 2018;5(2):145-158. doi: 10.3233/JND-180304. J Neuromuscul Dis. 2018. PMID: 29614695 Free PMC article.

6

Revised Recommendations for the Treatment of Infants Diagnosed with Spinal Muscular Atrophy Via Newborn Screening Who Have 4 Copies of SMN2.

Glascock J, Sampson J, Connolly AM, Darras BT, Day JW, Finkel R, Howell RR, Klinger KW, Kuntz N, Prior T, Shieh PB, Crawford TO, Kerr D, Jarecki J. Glascock J, et al. J Neuromuscul Dis. 2020;7(2):97-100. doi: 10.3233/JND-190468. J Neuromuscul Dis. 2020. PMID: 32007960 Free PMC article. No abstract available.

7

Newborn Screening and Birth Prevalence for Spinal Muscular Atrophy in the US.

Belter L, Taylor JL, Jorgensen E, Glascock J, Whitmire SM, Tingey JJ, Schroth M. Belter L, et al. Among authors: glascock j. JAMA Pediatr. 2024 Sep 1;178(9):946-949. doi: 10.1001/jamapediatrics.2024.1911. JAMA Pediatr. 2024. PMID: 39008286 Free PMC article.

8

Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy.

Kaifer KA, Villalón E, Osman EY, Glascock JJ, Arnold LL, Cornelison DDW, Lorson CL. Kaifer KA, et al. Among authors: glascock jj. JCI Insight. 2017 Mar 9;2(5):e89970. doi: 10.1172/jci.insight.89970. JCI Insight. 2017. PMID: 28289706 Free PMC article.

9

Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy.

Cobb MS, Rose FF, Rindt H, Glascock JJ, Shababi M, Miller MR, Osman EY, Yen PF, Garcia ML, Martin BR, Wetz MJ, Mazzasette C, Feng Z, Ko CP, Lorson CL. Cobb MS, et al. Among authors: glascock jj. Hum Mol Genet. 2013 May 1;22(9):1843-55. doi: 10.1093/hmg/ddt037. Epub 2013 Feb 5. Hum Mol Genet. 2013. PMID: 23390132

10

Defining the therapeutic window in a severe animal model of spinal muscular atrophy.

Robbins KL, Glascock JJ, Osman EY, Miller MR, Lorson CL. Robbins KL, et al. Among authors: glascock jj. Hum Mol Genet. 2014 Sep 1;23(17):4559-68. doi: 10.1093/hmg/ddu169. Epub 2014 Apr 9. Hum Mol Genet. 2014. PMID: 24722206 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters